Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
about
The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors.Cbx3 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration and Neointima Formation.CBX3/HP1γ is upregulated in tongue squamous cell carcinoma and is associated with an unfavorable prognosis.Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
P2860
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
@en
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
@nl
type
label
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
@en
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
@nl
prefLabel
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
@en
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells.
@nl
P2093
P2860
P356
P1433
P1476
Cbx3/HP1γ deficiency confers enhanced tumor-killing capacity on CD8+ T cells
@en
P2093
Bandana Sharma
Chie Naruse
Duc-Hung Pham
Masahide Asano
Matthew E Pipkin
Michael Sun
Rani E George
To-Ha Thai
P2860
P2888
P356
10.1038/SREP42888
P407
P577
2017-02-21T00:00:00Z